Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vera Hirsh

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Anti-Cancer Agents in Medicinal Chemistry|August 26, 2011
Vera Hirsh
Expert Review of Anticancer Therapy|January 29, 2014
nab-paclitaxel for the management of patients with advanced non-small-cell lung cancerVera Hirsh
World Journal of Clinical Oncology|June 14, 2014
Are the data on quality of life and patient reported outcomes from clinical trials of metastatic non-small-cell lung cancer important?Vera Hirsh
Annals of Palliative Medicine|April 6, 2015
Denosumab will play an important role in patients with solid tumours and bone metastasesVera Hirsh
Frontiers in Oncology|July 2, 2014
Targeted treatments of bone metastases in patients with lung cancerVera Hirsh
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 1, 2015
Next-Generation Covalent Irreversible Kinase Inhibitors in NSCLC: Focus on AfatinibVera Hirsh
Current Oncology (Toronto, Ont.)|December 15, 2010
Encouraging data out of the 2010 Congress of the European Society for Medical Oncology with respect to non-small-cell lung cancerVera Hirsh
Future Oncology (London, England)|July 8, 2011
Afatinib (BIBW 2992) development in non-small-cell lung cancerVera Hirsh
World Journal of Clinical Oncology|July 21, 2011
Review of the treatment of metastatic non small cell lung carcinoma: A practical approachVera Hirsh
Oncotargets and Therapy|May 27, 2017
New developments in the treatment of advanced squamous cell lung cancer: focus on afatinibVera Hirsh
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Anti-Cancer Agents in Medicinal Chemistry|August 26, 2011
Vera Hirsh
Expert Review of Anticancer Therapy|January 29, 2014
nab-paclitaxel for the management of patients with advanced non-small-cell lung cancerVera Hirsh
World Journal of Clinical Oncology|June 14, 2014
Are the data on quality of life and patient reported outcomes from clinical trials of metastatic non-small-cell lung cancer important?Vera Hirsh
Annals of Palliative Medicine|April 6, 2015
Denosumab will play an important role in patients with solid tumours and bone metastasesVera Hirsh
Frontiers in Oncology|July 2, 2014
Targeted treatments of bone metastases in patients with lung cancerVera Hirsh
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 1, 2015
Next-Generation Covalent Irreversible Kinase Inhibitors in NSCLC: Focus on AfatinibVera Hirsh
Current Oncology (Toronto, Ont.)|December 15, 2010
Encouraging data out of the 2010 Congress of the European Society for Medical Oncology with respect to non-small-cell lung cancerVera Hirsh
Future Oncology (London, England)|July 8, 2011
Afatinib (BIBW 2992) development in non-small-cell lung cancerVera Hirsh
World Journal of Clinical Oncology|July 21, 2011
Review of the treatment of metastatic non small cell lung carcinoma: A practical approachVera Hirsh
Oncotargets and Therapy|May 27, 2017
New developments in the treatment of advanced squamous cell lung cancer: focus on afatinibVera Hirsh
Pageof 10